ATE499381T1 - Hsp70 aus arthrobacter - Google Patents

Hsp70 aus arthrobacter

Info

Publication number
ATE499381T1
ATE499381T1 AT03763840T AT03763840T ATE499381T1 AT E499381 T1 ATE499381 T1 AT E499381T1 AT 03763840 T AT03763840 T AT 03763840T AT 03763840 T AT03763840 T AT 03763840T AT E499381 T1 ATE499381 T1 AT E499381T1
Authority
AT
Austria
Prior art keywords
arthrobacter
hsp70
sequenced
fish
believed
Prior art date
Application number
AT03763840T
Other languages
English (en)
Inventor
Steven Griffiths
Rachel Ritchie
Nathalie Simard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9940485&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE499381(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE499381T1 publication Critical patent/ATE499381T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/827—Bacterial vaccine for fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT03763840T 2002-07-15 2003-07-14 Hsp70 aus arthrobacter ATE499381T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216414.3A GB0216414D0 (en) 2002-07-15 2002-07-15 Organic compounds
PCT/EP2003/007602 WO2004007539A2 (en) 2002-07-15 2003-07-14 Hsp70 from arthrobacter

Publications (1)

Publication Number Publication Date
ATE499381T1 true ATE499381T1 (de) 2011-03-15

Family

ID=9940485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03763840T ATE499381T1 (de) 2002-07-15 2003-07-14 Hsp70 aus arthrobacter

Country Status (15)

Country Link
US (1) US7674892B2 (de)
EP (1) EP1523497B1 (de)
JP (1) JP5362167B2 (de)
CN (1) CN100378124C (de)
AT (1) ATE499381T1 (de)
AU (1) AU2003250943B2 (de)
BR (1) BR0312700A (de)
CA (1) CA2492556C (de)
CL (1) CL2007002806A1 (de)
DE (1) DE60336141D1 (de)
DK (1) DK1523497T3 (de)
GB (1) GB0216414D0 (de)
NO (1) NO337573B1 (de)
TW (1) TWI332989B (de)
WO (1) WO2004007539A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303507D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
DE102005010288A1 (de) * 2005-03-02 2006-09-07 Riemser Arzneimittel Ag Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung
BRPI0720729A2 (pt) * 2006-12-29 2014-04-08 Revance Therapeutics Inc Moléculas de transporte que utilizam polipeptídeos hiv-tat de sequência inversa.
US8540985B2 (en) * 2008-06-26 2013-09-24 Orphazyme Aps Use of Hsp70 as a regulator of enzymatic activity
US9345760B2 (en) 2011-09-09 2016-05-24 Advanced Bionutrition Corporation IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
US8450107B1 (en) 2011-11-30 2013-05-28 The Broad Institute Inc. Nucleotide-specific recognition sequences for designer TAL effectors
WO2013143700A2 (en) * 2012-03-27 2013-10-03 Curevac Gmbh Artificial nucleic acid molecules comprising a 5'top utr
CN103405763A (zh) * 2013-07-15 2013-11-27 中国科学院海洋研究所 热休克蛋白70作为免疫佐剂的应用
KR20210059796A (ko) 2016-04-29 2021-05-25 오르파짐 에이/에스 글루코세레브로시다제 연관 장애를 치료하기 위한 아리모클로몰
CN106282196A (zh) * 2016-08-20 2017-01-04 辽宁省海洋水产科学研究院 中华绒螯蟹hsp90基因克隆及其应用
KR20230128462A (ko) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정
MX2024010082A (es) * 2022-02-22 2024-08-27 Nissui Corp Metodo de vacunacion y peces de cultivo.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2666588B1 (fr) * 1990-09-10 1994-02-11 Pasteur Institut Sequence nucleotidique regulatrice de l'initiation de transcription.
GB9701897D0 (en) * 1997-01-30 1997-03-19 Aqua Health Europ Ltd Vaccine
EP1637614A3 (de) 1999-08-07 2006-11-29 Novartis AG Nukleinsäure und Antikörper zum Nachweis von infektiösem Lachsanämievirus
EP1222289B1 (de) * 1999-10-20 2008-04-16 The Johns Hopkins University School Of Medicine Chimäre immunogene zusammensetzungen und dafür kodierende nukleinsäure
AU2001240791A1 (en) * 2000-03-11 2001-09-24 Novartis Ag Sequence
WO2002004018A2 (en) * 2000-07-10 2002-01-17 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity

Also Published As

Publication number Publication date
CN1668638A (zh) 2005-09-14
NO20050721L (no) 2005-04-14
AU2003250943B2 (en) 2007-08-16
CN100378124C (zh) 2008-04-02
CA2492556A1 (en) 2004-01-22
EP1523497A2 (de) 2005-04-20
CA2492556C (en) 2014-09-16
NO337573B1 (no) 2016-05-09
JP2006514537A (ja) 2006-05-11
WO2004007539A3 (en) 2004-02-19
JP5362167B2 (ja) 2013-12-11
DE60336141D1 (en) 2011-04-07
HK1075901A1 (en) 2005-12-30
US7674892B2 (en) 2010-03-09
AU2003250943A1 (en) 2004-02-02
WO2004007539A2 (en) 2004-01-22
NO20050721D0 (no) 2005-02-10
EP1523497B1 (de) 2011-02-23
DK1523497T3 (da) 2011-05-16
US20050136071A1 (en) 2005-06-23
BR0312700A (pt) 2005-04-19
GB0216414D0 (en) 2002-08-21
TW200401827A (en) 2004-02-01
CL2007002806A1 (es) 2008-02-01
TWI332989B (en) 2010-11-11

Similar Documents

Publication Publication Date Title
CL2007002806A1 (es) Composicion de vacuna que comprende material celular de arthrobacter muerto; y su uso como inmunoestimulante para peces (div. sol. 1426-03).
PL374782A1 (en) Animal protein free media for cultivation of cells
AU2002357287A1 (en) Method to enhance reproductive performance in poultry
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
JP2004517472A5 (de)
GEP20074091B (en) Cripto blocking antibodies and uses thereof
IL164588A0 (en) ogenitor cells Novel methods for the invitro identification, isolation and differention of vasculogenic progenic pr
WO2004001019A3 (en) Novel nanoparticles and use thereof
UA42089C2 (uk) Протигрипозна вакцина на основі поверхневого антигену, спосіб її виробництва
AU2003277282A8 (en) The isolation, culture, and use of marine copepods in aquaculture
YU28503A (sh) Humanizovana anti-lt-beta-r antitela
DE602004005055D1 (de) Nahrungsmittelzusammensetzung
AU2002243443A1 (en) Method and composition for inhibition of tumor growth and enhancing an immune response
CY1109349T1 (el) Hsp60 απο arthrobacter
ATE419008T1 (de) Adjuvante zusammensetzung und anwendungsverfahren dafür
PT1276763E (pt) Proteinas anti-congelantes sua producao e utilizacao
AU1622302A (en) Preservation of cells
DE60123034D1 (de) Herstellung von sekundären aminoisobutylalkoxysilanen
SI1523330T1 (sl) Cepivo proti rikecialni septikemiji lososov na osnovi arthrobacter celic
TH64157A (th) Hsp70 จากอาร์โทรแบคเตอร์ (Arthrobacter)
AU2002217911A1 (en) Basal cell carcinoma cultures, methods related thereto and their use
PL358081A1 (en) Inclusion bodies as antigenes in oral immunization of animals
CN205823066U (zh) 一种具有防水隔热功能的门板
EP1409014B8 (de) Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten
Omidyar Erratum to: Mobile and Wireless Communications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties